E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects is a research paper published in JCI Insight (2021). On theSindex it has a DataRank of 0.477. It has been cited 23 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.477
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH/NHLBI
Grant: R01 HL121262
NIH/NHLBI
Grant: R01 HL133751
NIH/NHLBI
Grant: STTR R42HL127802
NIH/NHLBI
Grant: R01 HL153195
NIH/NHLBI
Grant: T32 HL144470
NIH/NIAMS
Grant: K24 AR060297
The SmartState and Kitty Trask Holt Endowment
Grant: N/A
NHLBI NIH HHS
Grant: R42 HL127802
NCATS NIH HHS
Grant: TL1 TR001451
National Institutes of Health
Grant: 5R01HL153195-04
IGF-II regulates lung fibrosis in scleroderma
National Institutes of Health
Grant: 7K24AR060297-02
Scleroderma Twin Study
National Institutes of Health
Grant: 5R01HL133751-02
Role of pericytes in scleroderma skin and lung fibrosis
National Institutes of Health
Grant: 1R42HL127802-01
Peptide Based Therapy for Lung Fibrosis
National Institutes of Health
Grant: 5R01HL121262-02
Mechanism of Action of Anti-Fibrotic Peptide
National Institutes of Health
Grant: 5T32HL144470-03
Pulmonary Focused Foundations in Innovation and Scholarship (PuFFInS)
FWCI
1.04
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals